Diagnostic value of sonazoid for hepatic metastasis: Comparison with FDG PET/CT

Hepato-Gastroenterology

Volumn 57, Issue 102-103, 2010, Pages 1237-1240

  Hiraoka, Atsushi ^a   Kume, Misaki ^a   Miyagawa, Masao ^a   Tazuya, Nayu ^a   Ichiryu, Misa ^a   Ochi, Hironori ^a,b   Tanabe, Atsushi ^a   Nakahara, Hiromasa ^a   Shinbata, Yuki ^a   Kan, Miki ^a   Doi, Shigekazu ^a   Hidaka, Satoshi ^a   Uehara, Takahide ^a   Tanihira, Tetsuya ^a   Hasebe, Aki ^a   Miyamoto, Yasunao ^a   Ninomiya, Tomoyuki ^a   Hirooka, Masashi ^b   Abe, Masanori ^b   Hiasa, Yoichi ^b   Matsuura, Bunzo ^b   Onji, Morikazu ^b   Michitaka, Kojiro ^a   more..

^a EHIME PREFECTURAL CENTRAL HOSPITAL   (Japan)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Contrast enhanced sonography; FDG PET CT; Gastrointestinal tract cancer; Hepatic metastasis; Sonazoid

Indexed keywords

FLUORODEOXYGLUCOSE F 18; PERFLUBUTANE;

ABDOMINAL RADIOGRAPHY; ADULT; AGED; ARTICLE; BODY MASS; COLORECTAL CANCER; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIGESTIVE SYSTEM CANCER; DUODENUM CANCER; ESOPHAGUS CANCER; FEMALE; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STOMACH CANCER;

AGED; CONTRAST MEDIA; FERRIC COMPOUNDS; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE ENHANCEMENT; IRON; LIVER NEOPLASMS; MIDDLE AGED; OXIDES; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79251535919     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Kinkel K, Lu Y, Both M, et al: Detection of hepatic metastasis from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 2002; 224:748-756.
2. Abdel-Nabi H, Doerr RJ, Lamonica DM, et al: Staging primary colorectal carcinomas with fluorine-18 fluorode-oxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology 1998; 206:755-760.
3. Kindberg GM, Tolleshaug H, Roos N, et al: Hepatic clearance of Sonazoid perfluorobutane microbubbles by Kupffer cells does not reduce the ability of liver to phagocytose or degrade albumin microspheres. Cell Tissue Res 2003; 312:49-54.
4. Kan M, Hiraoka A, Uehara T, et al: Evaluation of contrast-enhanced ultrasonography using perfluorobutane (Sonazoid) in patients with small hepatocellular carcinoma: comparison with dynamic computed tomography. Oncol Lett 2010; 1:485-488.
5. Hiraoka A, Ichiryu M, Tazuya N, et al: Clinical translation in the treatment of hepatocellular carcinoma following the introduction of contrast-enhanced ultrasonography with Sonaziod. Oncol Lett 2010; 1:57-62.
6. Hatanaka K, Kudo M, Minami Y, Maekawa K: Sonazoid-enhanced ultrasonography for diagnosis of hepatic malignancies: comparison with contrast-enhanced CT. Oncology 2008; 75:42-47.
7. Kudo M, Hatanaka K, Chung H, et al: A proposal of novel treatment assist technique for hepatocellular carcinoma in the Sonazoid-enhanced ultrasonography: value of detect re-perfusion imaging. Kanzo 2007 in Japanese; 48:299-301.
8. Numata K, Morimoto M, Ogura M, et al: Ablation therapy guided by contrast-enhanced sonography with Sonazoid for hepatocellular carcinoma lesions not detected by conventional sonography. J Ultrasound Med 2008; 27:395-406. (Pubitemid 351428123)
9. Tsunoda Y, Ito M, Fujii H, Kuwano H, Saito N, et al: Preoperative diagnosis of lymph node metases of colorectal cancer by FDG PET/CT. Jpn J Clin Oncol 2008; 38:347-353. (Pubitemid 351753566)